Chief Business & Strat Officer Delong Mark Jeffrey sold $73,371 worth of shares (3,371 units at $21.77), decreasing direct ownership by 4% to 78,353 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

APLS· Apellis Pharmaceuticals Inc.

Health Care

Original source

Chief Business & Strat Officer Delong Mark Jeffrey sold $73,371 worth of shares (3,371 units at $21.77), decreasing direct ownership by 4% to 78,353 units (SEC Form 4) | Quantisnow